Creative Planning’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2
| Closed | -$86 | – | 3756 |
|
|
2024
Q4 | $86 | Buy |
+2
| New | +$91 | ﹤0.01% | 3579 |
|
|
2022
Q2 | – | Sell |
-201
| Closed | -$9K | – | 2565 |
|
|
2022
Q1 | $9K | Buy |
+201
| New | +$8.83K | ﹤0.01% | 2206 |
|
|
2018
Q1 | – | Sell |
-11,488
| Closed | -$500K | – | 2134 |
|
|
2017
Q4 | $500K | Buy |
+11,488
| New | +$489K | ﹤0.01% | 1066 |
|
|
2017
Q3 | – | Sell |
-4,501
| Closed | -$194K | – | 3750 |
|
|
2017
Q2 | $194K | Buy |
4,501
+3,000
| +200% | +$126K | ﹤0.01% | 1534 |
|
|
2017
Q1 | $63K | Sell |
1,501
-4,987
| -77% | -$203K | ﹤0.01% | 2307 |
|
|
2016
Q4 | $254K | Buy |
6,488
+2,856
| +79% | +$116K | ﹤0.01% | 1280 |
|
|
2016
Q3 | $161K | Sell |
3,632
-3,274
| -47% | -$149K | ﹤0.01% | 1535 |
|
|
2016
Q2 | $289K | Sell |
6,906
-9,166
| -57% | -$388K | ﹤0.01% | 1078 |
|
|
2016
Q1 | $647K | Buy |
16,072
+11,324
| +239% | +$480K | 0.01% | 661 |
|
|
2015
Q4 | $243K | Sell |
4,748
-7,648
| -62% | -$390K | ﹤0.01% | 1094 |
|
|
2015
Q3 | $582K | Buy |
+12,396
| New | +$747K | 0.01% | 679 |
|
|
2015
Q2 | – | Sell |
-5,116
| Closed | -$316K | – | 3065 |
|
|
2015
Q1 | $316K | Buy |
5,116
+2,112
| +70% | +$125K | ﹤0.01% | 967 |
|
|
2014
Q4 | $162K | Sell |
3,004
-1,100
| -27% | -$60.1K | ﹤0.01% | 1269 |
|
|
2014
Q3 | $218K | Buy |
4,104
+2,020
| +97% | +$103K | ﹤0.01% | 1013 |
|
|
2014
Q2 | $108K | Buy |
2,084
+522
| +33% | +$25.2K | ﹤0.01% | 1387 |
|
|
2014
Q1 | $73K | Buy |
1,562
+1,112
| +247% | +$52.5K | ﹤0.01% | 1585 |
|
|
2013
Q4 | $20K | Sell |
450
-828
| -65% | -$34.5K | ﹤0.01% | 2196 |
|
|
2013
Q3 | $49K | Buy |
1,278
+828
| +184% | +$31.3K | ﹤0.01% | 1521 |
|
|
2013
Q2 | $16K | Buy |
+450
| New | +$15.2K | ﹤0.01% | 2062 |
|
Other funds holding XPH
KWM
FCBT
